The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk factors associated with ifosfamide (IFOS)-induced encephalopathy in patients (pts) with metastatic (Met) sarcoma (Sarc).
 
Adebayo Ogunniyi
No Relationships to Disclose
 
Anjali Varma Desai
No Relationships to Disclose
 
Troy Z Horvat
Consulting or Advisory Role - Genentech
 
Li-Xuan Qin
No Relationships to Disclose
 
Ping Chi
Honoraria - Novartis
 
Mark Andrew Dickson
No Relationships to Disclose
 
Mrinal M. Gounder
Honoraria - Amgen; Daiichi Sankyo; Karyopharm Therapeutics; TRACON Pharma
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Epizyme; Karyopharm Therapeutics
Speakers' Bureau - Amgen
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Karyopharm Therapeutics
 
Mary Louise Keohan
No Relationships to Disclose
 
William D. Tap
Consulting or Advisory Role - Adaptimmune; Daiichi Sankyo; Eisai; EMD Serono; Immune Design; Janssen; Lilly; Novartis; Plexxikon; TRACON Pharma
 
Sandra P. D'Angelo
Consulting or Advisory Role - Amgen; EMD Serono; Nektar